Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma
Blood and Lymphatic Cancer: Targets and Therapy · 2017
DOI: 10.2147/blctt.s110665 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2017. Verfasst von Melody B Oncale und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, lnastoupil@mdan…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, lnastoupil@mdanderson.org.
Zitieren
APA
Oncale, M. B., Maymani, H., & Nastoupil, L. J. (2017). Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma. Blood and Lymphatic Cancer: Targets and Therapy. https://doi.org/10.2147/blctt.s110665
Vancouver
Oncale MB, Maymani H, Nastoupil LJ. Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma. Blood and Lymphatic Cancer: Targets and Therapy. 2017. doi:10.2147/blctt.s110665
BibTeX
@article{Oncale2017,
author = {Oncale, Melody B and Maymani, Hossein and Nastoupil, Loretta J},
title = {Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2017},
doi = {10.2147/blctt.s110665}
}
EUVIMED